Cart
sales@molnova.com
Ethosuximide
CAS No. 77-67-8
Ethosuximide( CI-366 | NSC 64013 )
Catalog No. M15932 CAS No. 77-67-8
An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 54 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | 33 | In Stock |
|
| 500MG | 49 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameEthosuximide
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
-
DescriptionAn anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.
-
In Vitro——
-
In Vivo——
-
SynonymsCI-366 | NSC 64013
-
PathwayGPCR/G Protein
-
TargetCalcium Channel
-
RecptorCalcium Channel
-
Research AreaOther Indications
-
Indication——
Chemical Information
-
CAS Number77-67-8
-
Formula Weight141.17
-
Molecular FormulaC7H11NO2
-
Purity>98% (HPLC)
-
SolubilityWater: 39.2 g/L
-
SMILESO=C(C(C)(CC)C1)NC1=O
-
Chemical Name3-Ethyl-3-methyl-2,5-pyrrolidinedione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Gomora JC, et al. Mol Pharmacol. 2001 Nov; 60(5):1121-32.
molnova catalog
related products
-
SR33805
SR33805 is a potent antagonist of Ca2+ channel(EC50s of 4.1 nM and 33 nM in depolarized and polarized conditions, respectively)Acute treatment with SR33805 restored the MI-altered cell shortening without affecting the Ca(2+) transient amplitude, suggesting an increase of myofilament Ca(2+) sensitivity in MI myocytes.?
-
Nexopamil
Nexopamil (LU-49938) is a calcium channel antagonist and a 5-hydroxytryptamine 2A receptor antagonist.
-
Calcium Channel anta...
Calcium Channel antagonist 2 is a calcium channel antagonist (IC50=5-20 μM) that can be used to study diseases due to Ca2+ channels like pain and diabetes.
